Percutaneous coronary revascularisation: is it ever worth what it costs?

AUTOR(ES)

Mark, Daniel B

FONTE

BMJ Group

RESUMO

“How could percutaneous coronary intervention without the risks and morbidities of heart surgery not be of benefit to patients? Hard experience teaches that such attractive “pathophysiological” simplifications are unreliable guides to practice and paradoxically may lead to worse rather than better treatment decisions”

Documentos Relacionados

• Indications for coronary revascularisation: a Dutch perspective.
• Management of hyperlipidaemia after coronary revascularisation: follow up study
• Coronary revascularisation: why do rates vary geographically in the UK?
• The Howie Code: what are the real costs?
• Health: What Is It Worth? Measures of Health Benefits